12 insiders reported 42 Form 4 transactions for Aardvark Therapeutics, Inc. (AARD) over the past 18 months (most recent 2025-12-12). Recent activity: Lee Tien-Li (Chief Executive Officer) Buy 7,000 shares, Sun Nelson (Chief Financial Officer) Buy 3,000 shares, Lee Tien-Li (Chief Executive Officer) Buy 1,229 shares, Jones Bryan (Chief Operating Officer) Buy 1,250 shares, Lee Tien-Li (Chief Executive Officer) Buy 6,500 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-12 | Lee Tien-Li | Chief Executive Officer | Buy | 7,000 | $101,430 |
| 2025-12-12 | Sun Nelson | Chief Financial Officer | Buy | 3,000 | $43,200 |
| 2025-10-16 | Lee Tien-Li | Chief Executive Officer | Buy | 1,229 | $5,211 |
| 2025-10-16 | Jones Bryan | Chief Operating Officer | Buy | 1,250 | $5,300 |
| 2025-09-16 | Lee Tien-Li | Chief Executive Officer | Buy | 6,500 | $61,815 |
| 2025-09-16 | Lee Tien-Li | Chief Executive Officer | Buy | 3,500 | $34,790 |
| 2025-09-12 | Lee Tien-Li | Chief Executive Officer | Buy | 9,000 | $71,190 |
| 2025-09-12 | Lee Tien-Li | Chief Executive Officer | Buy | 6,000 | $46,920 |
| 2025-09-12 | Lee Tien-Li | Chief Executive Officer | Buy | 5,000 | $42,500 |
| 2025-09-10 | Sun Nelson | Chief Financial Officer | Buy | 6,000 | $48,420 |
| 2025-08-29 | Lee Tien-Li | Chief Executive Officer | Buy | 17,209 | $72,966 |
| 2025-02-19 | Sun Nelson | Chief Financial Officer | Buy | 10,000 | $160,000 |
| 2025-02-19 | Sun Nelson | Chief Financial Officer | Buy | 7,001 | $0 |
| 2025-02-19 | Decheng Capital Global Life Sciences Fund IV, L.P. | Insider | Buy | 2.3M | $0 |
| 2025-02-19 | Decheng Capital Management IV (Cayman), LLC | Insider | Buy | 2.3M | $0 |
| 2025-02-19 | Cui Xiangmin | Insider | Buy | 2.3M | $0 |
| 2025-02-19 | Decheng Capital Global Healthcare GP, LLC | Insider | Buy | 2.3M | $0 |
| 2025-02-19 | Decheng Capital Global Healthcare Fund (Master), LP | Insider | Buy | 2.3M | $0 |
| 2025-02-19 | Decheng Capital Global Healthcare GP, LLC | Insider | Buy | 333,412 | $0 |
| 2025-02-19 | Decheng Capital Global Healthcare Fund (Master), LP | Insider | Buy | 333,412 | $0 |
| 2025-02-19 | Decheng Capital Global Life Sciences Fund IV, L.P. | Insider | Buy | 333,412 | $0 |
| 2025-02-19 | Cui Xiangmin | Insider | Buy | 333,412 | $0 |
| 2025-02-19 | Decheng Capital Management IV (Cayman), LLC | Insider | Buy | 333,412 | $0 |
| 2025-02-19 | Decheng Capital Management IV (Cayman), LLC | Insider | Buy | 625,000 | $10.0M |
| 2025-02-19 | Cui Xiangmin | Insider | Buy | 625,000 | $10.0M |
Source: SEC Form 4 filings · as of 2025-12-12